report cover

2023-2031 Report on Global Biologics and Biosimilars Market by Player, Region, Type, Application and Sales Channel

  • 23 May 2023
  • Life Sciences
  • 98 Pages
  • Report code : 24WT-7696330

Biologics and Biosimilars Market

Table of Contents

Chapter 1 Biologics and Biosimilars Market Overview
1.1 Biologics and Biosimilars Definition
1.2 Global Biologics and Biosimilars Market Size Status and Outlook (2017-2031)
1.3 Global Biologics and Biosimilars Market Size Comparison by Region (2017-2031)
1.4 Global Biologics and Biosimilars Market Size Comparison by Type (2017-2031)
1.5 Global Biologics and Biosimilars Market Size Comparison by Application (2017-2031)
1.6 Global Biologics and Biosimilars Market Size Comparison by Sales Channel (2017-2031)
1.7 Biologics and Biosimilars Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Russia-Ukraine War Impacts
Chapter 2 Biologics and Biosimilars Market Segment Analysis by Player
2.1 Global Biologics and Biosimilars Sales and Market Share by Player (2020-2022)
2.2 Global Biologics and Biosimilars Revenue and Market Share by Player (2020-2022)
2.3 Global Biologics and Biosimilars Average Price by Player (2020-2022)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Biologics and Biosimilars Market Segment Analysis by Type
3.1 Global Biologics and Biosimilars Market by Type
3.1.1 Monoclonal Antibodies
3.1.2 Interferon
3.1.3 Erythropoietin
3.1.4 Insulin
3.1.5 Vaccines
3.2 Global Biologics and Biosimilars Sales and Market Share by Type (2017-2022)
3.3 Global Biologics and Biosimilars Revenue and Market Share by Type (2017-2022)
3.4 Global Biologics and Biosimilars Average Price by Type (2017-2022)
3.5 Leading Players of Biologics and Biosimilars by Type in 2022
3.6 Conclusion of Segment by Type
Chapter 4 Biologics and Biosimilars Market Segment Analysis by Application
4.1 Global Biologics and Biosimilars Market by Application
4.1.1 Tumor
4.1.2 Diabetes
4.1.3 Cardiovascular
4.1.4 Hemophilia
4.1.5 Other
4.2 Global Biologics and Biosimilars Revenue and Market Share by Application (2017-2022)
4.3 Leading Consumers of Biologics and Biosimilars by Application in 2022
4.4 Conclusion of Segment by Application
Chapter 5 Biologics and Biosimilars Market Segment Analysis by Sales Channel
5.1 Global Biologics and Biosimilars Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Biologics and Biosimilars Revenue and Market Share by Sales Channel (2017-2022)
5.3 Leading Distributors/Dealers of Biologics and Biosimilars by Sales Channel in 2022
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Biologics and Biosimilars Market Segment Analysis by Region
6.1 Global Biologics and Biosimilars Market Size and CAGR by Region (2017-2031)
6.2 Global Biologics and Biosimilars Sales and Market Share by Region (2017-2022)
6.3 Global Biologics and Biosimilars Revenue and Market Share by Region (2017-2022)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Biologics and Biosimilars Market Share by Type
6.4.3 North America Biologics and Biosimilars Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Biologics and Biosimilars Market Share by Type
6.5.3 Europe Biologics and Biosimilars Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Biologics and Biosimilars Market Share by Type
6.6.3 Asia-Pacific Biologics and Biosimilars Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Biologics and Biosimilars Market Share by Type
6.7.3 South America Biologics and Biosimilars Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Biologics and Biosimilars Market Share by Type
6.8.3 Middle East & Africa Biologics and Biosimilars Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Biologics and Biosimilars Players
7.1 Roche
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Amgen
7.3 AbbVie
7.4 Sanofi-Aventis
7.5 Johnson & Johnson
7.6 Pfizer
7.7 Novo Nordisk
7.8 Eli Lilly
7.9 Novartis
7.10 Merck
7.11 3sbio
7.12 Changchun High Tech
7.13 CP Guojian
7.14 Biotech
7.15 Gelgen
7.16 Innovent
7.17 Dong Bao
7.18 Ganlee
Chapter 8 Upstream and Downstream Analysis of Biologics and Biosimilars
8.1 Industrial Chain of Biologics and Biosimilars
8.2 Upstream of Biologics and Biosimilars
8.3 Downstream of Biologics and Biosimilars
Chapter 9 Development Trend of Biologics and Biosimilars (2023-2031)
9.1 Global Biologics and Biosimilars Market Size (Sales and Revenue) Forecast (2023-2031)
9.2 Global Biologics and Biosimilars Market Size and CAGR Forecast by Region (2023-2031)
9.3 Global Biologics and Biosimilars Market Size and CAGR Forecast by Type (2023-2031)
9.4 Global Biologics and Biosimilars Market Size and CAGR Forecast by Application (2023-2031)
9.5 Global Biologics and Biosimilars Market Size and CAGR Forecast by Sales Channel (2023-2031)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification

Ask Our Expert

Leave This Empty:

*Required Information
List of Tables and Figures

Figure Biologics and Biosimilars Example
Figure Global Biologics and Biosimilars Revenue (Million $) Status and Outlook (2017-2031)
Figure Global Biologics and Biosimilars Revenue (Million $) Comparison by Region (2017-2031)
Figure Global Biologics and Biosimilars Revenue (Million $) Comparison by Type (2017-2031)
Figure Global Biologics and Biosimilars Revenue (Million $) Comparison by Application (2017-2031)
Figure Global Biologics and Biosimilars Revenue (Million $) Comparison by Sales Channel (2017-2031)
Table Global Biologics and Biosimilars Sales by Player (2020-2022)
Table Global Biologics and Biosimilars Sales Market Share by Player (2020-2022)
Figure Global Biologics and Biosimilars Sales Market Share by Player in 2022
Table Global Biologics and Biosimilars Revenue (Million $) by Player (2020-2022)
Table Global Biologics and Biosimilars Revenue Market Share by Player (2020-2022)
Figure Global Biologics and Biosimilars Revenue Market Share by Player in 2022
Table Global Biologics and Biosimilars Average Price by Player (2020-2022)
Figure Global Biologics and Biosimilars Average Price by Player in 2022
Figure Global Biologics and Biosimilars Players Competition Situation ? Top 5 Players? Revenue Market Share in 2020
Figure Global Biologics and Biosimilars Players Competition Trends ? Top 5 Players? Revenue Market Share in 2022
Figure Example of Monoclonal Antibodies
Figure Global Monoclonal Antibodies Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Interferon
Figure Global Interferon Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Erythropoietin
Figure Global Erythropoietin Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Insulin
Figure Global Insulin Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Vaccines
Figure Global Vaccines Revenue (Million $) and Growth Rate (2017-2022)
Table Global Biologics and Biosimilars Sales by Type (2017-2022)
Table Global Biologics and Biosimilars Sales Market Share by Type (2017-2022)
Figure Global Biologics and Biosimilars Sales Market Share by Type in 2022
Table Global Biologics and Biosimilars Revenue (Million $) by Type (2017-2022)
Table Global Biologics and Biosimilars Revenue Market Share by Type (2017-2022)
Figure Global Biologics and Biosimilars Revenue Market Share by Type in 2022
Table Global Biologics and Biosimilars Average Price by Type (2017-2022)
Figure Global Biologics and Biosimilars Average Price by Type in 2022
Table Leading Players of Biologics and Biosimilars by Type in 2022
Figure Example of Tumor
Figure Global Biologics and Biosimilars for Tumor Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Diabetes
Figure Global Biologics and Biosimilars for Diabetes Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Cardiovascular
Figure Global Biologics and Biosimilars for Cardiovascular Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Hemophilia
Figure Global Biologics and Biosimilars for Hemophilia Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Other
Figure Global Biologics and Biosimilars for Other Revenue (Million $) and Growth Rate (2017-2022)
Table Global Biologics and Biosimilars Sales by Application (2017-2022)
Table Global Biologics and Biosimilars Sales Market Share by Application (2017-2022)
Figure Global Biologics and Biosimilars Sales Market Share by Application in 2022
Table Leading Consumers of Biologics and Biosimilars by Application in 2022
Figure Example of Direct Channel
Figure Global Biologics and Biosimilars for Direct Channel Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Distribution Channel
Figure Global Biologics and Biosimilars for Distribution Channel Revenue (Million $) and Growth Rate (2017-2022)
Table Global Biologics and Biosimilars Revenue by Sales Channel (2017-2022)
Table Global Biologics and Biosimilars Revenue Market Share by Sales Channel (2017-2022)
Figure Global Biologics and Biosimilars Revenue Market Share by Sales Channel in 2022
Table Leading Distributors/Dealers of Biologics and Biosimilars by Sales Channel in 2022
Table Global Biologics and Biosimilars Market Size and CAGR by Region (2017-2031)
Table Global Biologics and Biosimilars Sales by Region (2017-2022)
Table Global Biologics and Biosimilars Sales Market Share by Region (2017-2022)
Figure Global Biologics and Biosimilars Sales Market Share by Region in 2022
Table Global Biologics and Biosimilars Revenue (Million $) by Region (2017-2022)
Table Global Biologics and Biosimilars Revenue Market Share by Region (2017-2022)
Figure Global Biologics and Biosimilars Revenue Market Share by Region in 2022
Table North America Biologics and Biosimilars Sales by Country (2017-2022)
Figure North America Biologics and Biosimilars Sales Market Share by Country (2017-2022)
Table North America Biologics and Biosimilars Revenue by Country (2017-2022)
Figure North America Biologics and Biosimilars Revenue Market Share by Country (2017-2022)
Figure North America Biologics and Biosimilars Market Share by Type in 2022
Figure North America Biologics and Biosimilars Market Share by Application in 2022
Figure United States Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure United States Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Figure Canada Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure Canada Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Figure Mexico Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure Mexico Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Table Europe Biologics and Biosimilars Sales by Country (2017-2022)
Figure Europe Biologics and Biosimilars Sales Market Share by Country (2017-2022)
Table Europe Biologics and Biosimilars Revenue by Country (2017-2022)
Figure Europe Biologics and Biosimilars Revenue Market Share by Country (2017-2022)
Figure Europe Biologics and Biosimilars Market Share by Type in 2022
Figure Europe Biologics and Biosimilars Market Share by Application in 2022
Figure Germany Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure Germany Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Figure UK Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure UK Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Figure France Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure France Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Figure Italy Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure Italy Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Figure Russia Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure Russia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Figure Spain Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure Spain Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Table Asia-Pacific Biologics and Biosimilars Sales by Country (2017-2022)
Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Country (2017-2022)
Table Asia-Pacific Biologics and Biosimilars Revenue by Country (2017-2022)
Figure Asia-Pacific Biologics and Biosimilars Revenue Market Share by Country (2017-2022)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Type in 2022
Figure Asia-Pacific Biologics and Biosimilars Market Share by Application in 2022
Figure China Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure China Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Figure Japan Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure Japan Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Figure Korea Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure Korea Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Figure India Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure India Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Figure Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure Southeast Asia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Figure Australia Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure Australia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Table South America Biologics and Biosimilars Sales by Country (2017-2022)
Figure South America Biologics and Biosimilars Sales Market Share by Country (2017-2022)
Table South America Biologics and Biosimilars Revenue by Country (2017-2022)
Figure South America Biologics and Biosimilars Revenue Market Share by Country (2017-2022)
Figure South America Biologics and Biosimilars Market Share by Type in 2022
Figure South America Biologics and Biosimilars Market Share by Application in 2022
Figure Brazil Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure Brazil Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Figure Argentina Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure Argentina Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Figure Colombia Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure Colombia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Table Middle East & Africa Biologics and Biosimilars Sales by Country (2017-2022)
Figure Middle East & Africa Biologics and Biosimilars Sales Market Share by Country (2017-2022)
Table Middle East & Africa Biologics and Biosimilars Revenue by Country (2017-2022)
Figure Middle East & Africa Biologics and Biosimilars Revenue Market Share by Country (2017-2022)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Type in 2022
Figure Middle East & Africa Biologics and Biosimilars Market Share by Application in 2022
Figure UAE Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure UAE Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Figure Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure Saudi Arabia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Figure South Africa Biologics and Biosimilars Sales and Growth Rate (2017-2022)
Figure South Africa Biologics and Biosimilars Revenue (Million $) and Growth Rate (2017-2022)
Table Company Snapshot of Roche
Table Biologics and Biosimilars Introduction of Roche
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share of Roche (2020-2022)
Table Industrial Chain of Biologics and Biosimilars
Table Manufacturing Cost Structure of Biologics and Biosimilars
Table General Manufacturing Process of Biologics and Biosimilars
Table Leading Distributors/Dealers of Biologics and Biosimilars
Table Leading Consumers of Biologics and Biosimilars
Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast (2023-2031)
Figure Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2023-2031)
Table Global Biologics and Biosimilars Market Size and CAGR Forecast by Region (2023-2031)
Table Global Biologics and Biosimilars Market Size and CAGR Forecast by Type (2023-2031)
Table Global Biologics and Biosimilars Market Size and CAGR Forecast by Application (2023-2031)
Table Global Biologics and Biosimilars Market Size and CAGR Forecast by Sales Channel (2023-2031)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Biologics and Biosimilars Market

Leave This Empty: